1,2-Diphenyl-1,2-di-p-tolylethane-1,2-diol, 97%, 1g

2,2-Dimethylthiazolidine>98.0%(GC)25mL

1-(2,3-DIFLUOROPHENYL)CYCLOPROPANEMETHANAMINE, 95%, 100mg

2-Bromo-5-fluorocinnamic acid, 98.0%, 1kg

Resiquimod>98.0%(HPLC)100mg

2-Chloro-5-(4-trifluoromethylbenzoyl)pyridine, 97.0%, 1g

(R)-1-(3-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride, 97.0%, 100mg

2-{bicyclo[1.1.1]pentan-1-yl}propanoic acid, 97.0%, 500mg

3-(6-METHOXY-1H-INDOL-3-YL)-ACRYLIC ACID ETHYL ESTER, 95.0%, 2g

2-Amino-4-methyl-thiazole-5-carboxylic acid, 95.0%, 5g

5-Bromo-4-fluoro-2-iodo-1H-pyrrolo[2,3-b]pyridine, 98+%, 5g

tert-Butyl (2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)carbamate, 97%, 100mg

N2-(tert-butoxycarbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine, 97%, 5g